Submitting a statement in accordance with ICH E3, section 9.6
(i.e., whether investigator meetings or other steps were taken to prepare
investigators and standardize performance), is one acceptable means of
complying with 21 CFR 312.120(b)(11), provided that the description
includes how investigators were trained to comply with GCP and to
conduct the study in accordance with the study protocol.
